Eric Venker - 05 Jan 2023 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
President & COO
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker
Issuer symbol
ROIV
Transactions as of
05 Jan 2023
Transactions value $
-$192,777
Form type
4
Filing time
06 Jan 2023, 20:30:20 UTC
Previous filing
04 Jan 2023
Next filing
26 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Sale -$193K -24K -3.19% $8.02 729K 05 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022.